Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruonan Li

Showing results (241-250 of 256) with videos related to

Pageof 26
Sort By:
Science Advances|June 12, 2021
High-throughput functional screening for next-generation cancer immunotherapy using droplet-based microfluidicsYuan Wang, Ruina Jin, Bingqing Shen, et al.
Biorxiv : the Preprint Server for Biology|December 15, 2025
Deconvolution of Sparse-count RNA Sequencing Data for Tumor Cells Using Embedded Negative Binomial DistributionsMatthew D Montierth, Hao Yan, Liyang Xie, et al.
Frontiers in Immunology|February 16, 2026
Low-dose cyclophosphamide combined with standard immunosuppressive therapy improves early response rates in severe aplastic anemiaHong Pan, Zhen Gao, Lele Zhang, et al.
Biorxiv : the Preprint Server for Biology|May 18, 2026
Scalable subclonal reconstruction of cancer cells in DNA sequencing data using a penalized likelihood modelYujie Jiang, Matthew D Montierth, Yu Ding, et al.
Bioanalysis|June 28, 2024
Qualification of a 21-valent pneumococcal urine antigen detection assay and development of clinical positivity cutoffsArpita Choudhury, Yuhua Zhang, Junshui Ma, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 18, 2022
An armed oncolytic virus enhances the efficacy of tumor-infiltrating lymphocyte therapy by converting tumors to artificial antigen-presenting cells in situKai Ye, Fan Li, Ruikun Wang, et al.
Blood|May 26, 2026
L-Carnitine Regulates Regeneration of Human Hematopoietic Stem and Progenitor CellsHonglin Duan, Bohong Wang, Yawei Zheng, et al.
Cancer Immunology, Immunotherapy : CII|April 29, 2025
Targeting interleukin-2-inducible T cell kinase ameliorates immune-mediated aplastic anemiaWeiwang Li, Yu Lian, Lele Zhang, et al.
Clinical and Translational Medicine|July 29, 2025
Bispecific antibody targeting CD40 and HER2 potentiates therapeutic efficacy by reprogramming macrophages within the tumour microenvironmentNa Li, Ruonan Li, Qiongqiong Ma, et al.
Theranostics|January 7, 2021
A general Fc engineering platform for the next generation of antibody therapeuticsDa Chen, Yingjie Zhao, Mingyu Li, et al.
Pageof 26

Showing results (241-250 of 256) with videos related to

Sort By:
Pageof 26
Science Advances|June 12, 2021
High-throughput functional screening for next-generation cancer immunotherapy using droplet-based microfluidicsYuan Wang, Ruina Jin, Bingqing Shen, et al.
Biorxiv : the Preprint Server for Biology|December 15, 2025
Deconvolution of Sparse-count RNA Sequencing Data for Tumor Cells Using Embedded Negative Binomial DistributionsMatthew D Montierth, Hao Yan, Liyang Xie, et al.
Frontiers in Immunology|February 16, 2026
Low-dose cyclophosphamide combined with standard immunosuppressive therapy improves early response rates in severe aplastic anemiaHong Pan, Zhen Gao, Lele Zhang, et al.
Biorxiv : the Preprint Server for Biology|May 18, 2026
Scalable subclonal reconstruction of cancer cells in DNA sequencing data using a penalized likelihood modelYujie Jiang, Matthew D Montierth, Yu Ding, et al.
Bioanalysis|June 28, 2024
Qualification of a 21-valent pneumococcal urine antigen detection assay and development of clinical positivity cutoffsArpita Choudhury, Yuhua Zhang, Junshui Ma, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 18, 2022
An armed oncolytic virus enhances the efficacy of tumor-infiltrating lymphocyte therapy by converting tumors to artificial antigen-presenting cells in situKai Ye, Fan Li, Ruikun Wang, et al.
Blood|May 26, 2026
L-Carnitine Regulates Regeneration of Human Hematopoietic Stem and Progenitor CellsHonglin Duan, Bohong Wang, Yawei Zheng, et al.
Cancer Immunology, Immunotherapy : CII|April 29, 2025
Targeting interleukin-2-inducible T cell kinase ameliorates immune-mediated aplastic anemiaWeiwang Li, Yu Lian, Lele Zhang, et al.
Clinical and Translational Medicine|July 29, 2025
Bispecific antibody targeting CD40 and HER2 potentiates therapeutic efficacy by reprogramming macrophages within the tumour microenvironmentNa Li, Ruonan Li, Qiongqiong Ma, et al.
Theranostics|January 7, 2021
A general Fc engineering platform for the next generation of antibody therapeuticsDa Chen, Yingjie Zhao, Mingyu Li, et al.
Pageof 26